Almost half of clonoSEQ-tested patients receive the Clonality (ID) test using a fresh sample.

The type of specimen used for clonoSEQ MRD testing varies based on the patient’s diagnosis.

Patients are receiving longer-term MRD monitoring with clonoSEQ.

Nearly half of all patients who receive clonoSEQ MRD testing are monitored more frequently than once per year.

The demographics of clonoSEQ-tested patients are consistent with overall disease demographics.